Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
498 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Sentinel Node Detection in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Sentinel Node
Intervention: Procedure: Injection of radioactive tracer combined with Patent Blue
22 Recruiting KOrean Borderline Ovarian Tumor (KOBOT) Registry
Condition: Ovarian Neoplasms
Intervention:
23 Recruiting Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Regorafenib
24 Recruiting A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Device: ThermalCore Hyperthermia System
25 Recruiting Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
Conditions: Lynch Syndrome;   Endometrial Neoplasms;   Ovarian Neoplasms;   Colorectal Neoplasms
Intervention: Behavioral: Questionnaire, Educational Material
26 Recruiting The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
Condition: Ovarian Neoplasms
Intervention: Other: Observational cohort
27 Not yet recruiting Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Interventions: Drug: Part A: Dose Escalation of Cantrixil;   Drug: Part B: Expansion Cohort of Cantrixil;   Drug: Part C: Twice weekly dosing of Cantrixil
28 Not yet recruiting Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: entinostat;   Drug: avelumab;   Drug: Placebo
29 Recruiting Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer;   Peritoneum Tumors
Intervention: Behavioral: Data Collection
30 Recruiting A Study of WT1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube;   Primary Peritoneal Cancer;   Recurrent Ovarian Cancer
Interventions: Biological: WT1 Vaccine;   Drug: Nivolumab
31 Recruiting Mesenchymal Stem Cells (MSC) for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: MSC-INFβ;   Behavioral: Questionnaires
32 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
33 Recruiting GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Carcinomatosis;   Fallopian Tube Cancer
Intervention: Biological: GL-ONC1
34 Unknown  A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Lovastatin and Paclitaxel
35 Recruiting Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Malignant Neoplasms of Female Genital Organs;   Ovarian Cancer;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer
Interventions: Drug: Durvalumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Behavioral: Questionnaires;   Procedure: Debulking Surgery
36 Unknown  Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer
37 Unknown  Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Radiation: whole abdomen irradiation using IMRT
38 Recruiting Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm
Condition: Stage IIIC Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Cytoreduction
39 Recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer
Conditions: Malignant Ovarian Brenner Tumor;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Seromucinous Carcinoma;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Procedure: Mesenchymal Stem Cell Transplantation;   Biological: Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
40 Recruiting Ovarian Cancer Patient-Centered Decision Aid
Condition: Stage III Ovarian Cancer
Intervention: Other: Decision Aid

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years